THE CURE IS FOUND AGAINST THE HIV-AIDS VIRUS WITH A TROPICAL TREE IN BRAZIL CALL MGU-TANNIN MUTAMBA

SCIENTIFIC FIND THE CURE AGAINST HIV AIDS VIRUS WITH A TROPICAL TREEE IN BRAZIL CALL MUTAMBA, WITH OVER 100 CASES OF PATIENTS SUCCESSFULLY INOCULATED

At last the cure to be disseminated to the infected population Globally

Document Importance: Very High

Degree of sensitivity: Very sensitive

Document Type: Scientific

By: CENIC HEALTH CENTER Div

(Scientific Source: Dr. Paulo Antônio Rodrigues Gouveia)

A scientific research team advanced in Brazil Institute President Antonio Carlos Tocantinense (ITPAC) Araguaína city, in the northern Brazilian city of the state of Tocantins, successfully discovers the cure for HIV / AIDS, based on a laborious investigation of more than 10 years, under the Project scientist and Dr. Antonio Rodrigues Paulo Gouveia, investigating the properties of tropical plant called Mutamba (Guazuma Ulmifolia), so far more than 100 documented cases of patients successfully inoculated in the laboratory, in all tests, and since December 2013 now remains only the distribution and application across the globe to all infected patients and the relevant funding agency or by some world government that can be contacted with the Project leader Mutamba, as I call it. The big pharmaceutical, including WHO and PAHO have not reached yet, because the priest discovered is final and kill the virus in a period of approximately eight months, after application of the drug, and is not continuous in the time unlike dividends and revenues that can be obtained through the ARV's (antiretroviral conventional current), which offer higher profit corporations, until the death of the patient, not inoculate. The research team of Dr. Antonio Rodrigues Paulo Gouveia reportedly is willing to provide the support and collaboration of nations or governments directly or agencies and scientific institutions struggle which require, if necessary, to inoculate infected.

Dr. Antonio Rodrigues Paulo Gouveia, Advanced Project Manager, calls for several Progressive nations of the world and those who wish to join and Free Institutions in various nations, so they can contact you and make mass production of the compound, with your team, to implement the pilot production plant, the manufacturing process is simple, natural and safe, she says.

Across the globe there are over 40 million people infected in 2014 alone, recent data show that in Brazil alone, there are at least 750,000 infected and will progressively rise, even in groups without risk. Dr. Antonio Rodrigues Paulo Gouveia reported, it is not a job for just one person, but an organized and scientific team, which work with standard rules and guidelines, and is now ready to work for the sick and the planet and insists that it is everyone's job to defeat the virus. The cure is now available for immediate distribution to those affected globally, from August 2014, through a responsible agency says the scientist, not expecting indicates sick and can contact and published by the media. Informa governments and nations can contact through their ministries and institutions to implement Health Legal immediate inoculation protocol and include in their standard HIV programs.

WHAT IS AIDS ?

AIDS is a disease characterized by severe and progressive dysfunction of the immune system infected with human immunodeficiency virus (HIV) individual. Its evolution can be divided into three stages: acute infection, weeks after the initial infection may occur with manifestations such as fever, chills, sweating, myalgia, headache, sore throat, gastrointestinal symptoms, generalized lymphadenopathy, and rash . Most people develop self-limiting symptoms disappear after a few weeks. However, most are not diagnosed because of the similarity to other viral diseases. Then, the patient enters a stage of asymptomatic infection, variable duration of a few years. Symptomatic disease AIDS, which is its most severe manifestation occurs to the extent that the patient will present significant disturbances of immunity with the occurrence of prolonged fever, chronic diarrhea, significant weight loss (more than 10% by weight above the individual), night sweats, fatigue, and lymphadenopathy. Opportunistic infections begin to emerge or recur, such as tuberculosis, Pneumocystis carinii pneumonia, cerebral toxoplasmosis, oroesofágica candidiasis, cryptococcal meningitis and cytomegalovirus retinitis, among others. Rare in immunocompetent individuals, sarcoma and lymphoma and certain types of tumors may arise from sarcoma, characterized in AIDS condition. The occurrence of severe or atypical of tropical diseases such as paracoccidioidomycosis, leishmaniasis and Chagas disease forms have been observed in Brazil.

The Acquired Immunodeficiency Syndrome (AIDS) or "acquired immunodeficiency syndrome" (AIDS) began to spread among the population since 1980, has caused millions of infected people, and millions of deaths and the number of virus carriers is increasing alarmingly every year, increasing their number, including those outside of hazard or risk groups and this is alarming.

DIAGNOSTIC AIDS

The laboratory for HIV-A, by finding techniques to quantify antibodies, antigens, genetic material by molecular biology techniques (viral load) or direct virus isolation. In practice, tests that look for antibodies (serology) are the most used. The appearance of antibodies detectable by serology is an average period of 6 to 12 weeks after the initial infection. Called "window period" that the interval between infection and detection of antibodies by standard laboratory techniques. During this period, serological testing can be thrown or false negatives. Because of the importance of laboratory diagnosis, in particular the consequences of the "label" an individual as HIV positive and have increased security in the quality control of blood and its derivatives, it is recommended that testing laboratory reagents detection of a possible first sample was repeated and confirmed as required by the rules set by the Ministry of Health.

AIDS TREATMENT

-A Antiretroviral therapy addresses the prevention of viral replication, with different drugs that target various stages of the replicative cycle. Antiretroviral drugs currently available for treating HIV are various reverse transcriptase inhibitors that act prior to the incorporation of viral genetic material of the host chromosome and protease inhibitors, which then act in this step, and prevent virions forming functional proteins, namely, infectious virus. The cocktail is a combination of two drugs (Chi et al., 2004).

The reverse transcriptase inhibitors prevent the virus may change its genetic code in DNA-RNA, the operation required to multiply within the cells (Costi et al, 2004).

Several natural compounds are used in the studies of the inhibition of retroviral reverse transcriptase of HIV, including are tannins, phenolic compounds, these are characterized by their ability to combine with proteins or other polymers such as polysaccharides (Buolamwini and Assefa 2002 ).

Since the emergence of the AIDS virus, medicine has sought treatments that can increase the life expectancy of patients. The most effective so far, has been called the cocktail, consisting of pills patients need to take daily to combat the disease, called ARVs. For some HIV-positive, treatment is martyrdom, because they suffer with side effects such as nausea, diarrhea, stomach cramps and headaches motivated by the continued use of drugs and harmful side effects on their bodies and premature aging body. But these only stop the virus but do not eliminate it from the body.

ABOUT THE DISCOVERER OF SCIENTIFIC AND HEALING

Despite the progress, many researchers around the world are still trying to find a cure for the disease has become an epidemic worldwide. But it was in Tocantins, the physician and scientist Dr. Paul Anthony Rodrigues Gouveia (Paulo Antonio Rodrigues Gouveia), who in exclusive interviews several National Newspapers: The North Portal, the Daily Journal or Progresso and Araguaia News, I offer the specific details of their important research and discovery, based on a research project, studying healing, now short of people with HIV.

He lived for 40 years in Araguaína, Brazil, Dr. Paulo Gouveia, he worked as a laboratory technician at the Hospital for Tropical Diseases (HDT) and graduated in medicine for four years at the Institute Institute President Antonio Carlos Tocantinense (ITPAC) Araguaína . According to an official bulletin, working in health care in the State and County and offers training courses and conferences, ten years ago conducts scientific research that can change the course of history of medicine in the search for a cure AIDS, with very successful results. He found that through the properties of a plant called Mutamba, native to the northern clinic can cure this disease.

Dr. Paulo Gouveia, not only studied the properties of the plant, but also developed the project of healing, which is officially patented in Brazil and the scientific community.

WHAT IS THE MUTAMBA ?

The Mutamba is a tropical plant called scientific name, Guazuma Ulmifolia, Family Malvaceae (Antigamente Stherculiaceae). Mutamba, is a Tupi Guarani Indian word meaning "hard Fruit" also called Guazuma, Mutambo, Araticum bravo, Head-to-black, fruit or Macaco Chico-lean.

Origin: Born in several forest formations of Central and South America, appearing preferentially in the forests of Brazil.

http://floradobrasil.jbrj.gov.br/2012/index?mode=sv&group=Root_.Angiospermas_&family=Root_.Angiospermas_.Malvaceae_JUS&genus=Guazuma

JUSTIFICATION

The theoretical basis of the research of Dr. Paulo Gouveia, the work of his grandfather, also a scientist Dr. Francisco Cabral de Melo, pharmacist specialist, trained at the Federal University of Rio de Janeiro (UFRJ) in 1946 is based on Faina - Goiás, along with collaborators, document treatments in several patients with yellow fever, using tannin (accumulation of carbon, hydrogen and oxygen) of the plant popularly known as Pithecellobiun Mutamba or, in a typical plant tests northern region, and with a favorable prognosis, with several patients have already had healing by 100% of cases, without evidence of toxicity in any of them, being a natural product.

The substance tannin containing Mutamba the plant, through the cytoplasmic cell wall and reach the HIV virus even at distant places as lingonodos.

HOME TESTIMONY PROJECT

The scientist explains: Mutamba project began ten years ago, my mother always talked about my grandfather Francisco Cabral de Melo, pharmacist, my grandfather was undergoing treatment in 1946 patients with yellow fever, with a cure rate of one hundred percent. Later a doctor, I started researching and found the Guazulma ulmifolia better known as (Mutamba). The scientist then performed a research and started to introduce the bill on 23 October 2010, presented the project in Porto Alegre in Pastoral Aids, shortly after, got a contact Kyolab laboratories, with which they were performed and other evidence of inhibition were 30 percent, the tests were made by Dr. Amilcar Tanure, one of the best scientists or parents of cytology, Dr. Amilcar Tanure held retest which was 100 percent of inhibition without cytotoxicity, now, after four years of many struggles, we are here to continue the project functional. We need the support of the whole society, for this project to proceed that will help people not only in Brazil but in the world, to overcome this disease.

PROJECT DESCRIPTION

Their studies have shown that bark and inner bark Pithecellobiun known as (Mutamba) are rich in components with pharmacological properties. This presents triterpene alkaloids and a significant amount of tannin (Costi et al. 2004).

The properties of tannins are linked to their ability to form complex proteins involved in tissue protection, compared to microbiological attack. It also gives the taste properties grouped under the term astringency, has anti-free radical and can consume the energy of dissolved oxygen, ie, have interesting pharmacological properties and antioxidant function also show potent activity against HIV replication (Cocuzza, 2001).

GENERAL STUDY

To identify the effectiveness of the plant substrate Pithecellobiun (Mutamba) as an inhibitor of reverse transcriptase in viral replication (an enzyme that polymerizes DNA molecules from RNA molecules, often the opposite of what happens in cells) of HIV with reduced risk of toxicity.

SPECIFIC STUDY

• identify the molecular weight of tannin, which has an inhibitory action of retroviral reverse transcriptase of HIV, with lower risk of toxicity.

• Promote reduction in viral load while preserving the function of the immune system.

• Delaying disease progression by modifying the natural history of HIV.

BACKGROUND STUDY

Although the onset of therapy, decreases to undetectable viral particles, the virus persists in vessels in the body, such as T lymphocytes asleep. The appearance and the rate of development of resistance to various combinations of drugs available in the market stress is also a limiting factor. However, a factor that makes it even harder to anti-HIV therapy is the high incidence of side effects caused by medications available today. Studies by Ligani Jr. and colleagues showed that this is the main cause of failures in adherence to antiretroviral therapy (20.5%), which is mainly characterized by vomiting, diarrhea, nausea and abdominal pain as well as pain head and even changes in skin color.

The use of medicinal plants is the result of secular accumulation of empirical data on the stock of knowledge about plants of different ethnic groups. They are relevant to the standardization of production and marketing of herbal techniques important issues, however (De Clercq, 2000).

The herbs found in relatively high quantities of phenolic compounds. Its role is essential to protect the tissues against attack by insects, fungi or bacteria. Is considered a relatively efficient passive defense system. The plants may also produce large amounts of phenols from a change in the surface of living cells: protection is active. The best example is given by the bite of insects on the leaves that are the source of galls.

For ten years tree Mutamba was observed and realized that at some point in the year, had a strong presence of galls, dry reaching almost 70% commitment of the tree, and with each passing day the plant was recovering, showing resistance to blight that previously reached.

In 1946 Faina - GO, expert Francisco Cabral de Melo, Pharmaceutical UFRJ, and colleagues conducted tests, not documented in patients with yellow fever using Mutamba tannin which has a low molecular weight, with a favorable prognosis, and healing he was successful in 100% of cases, without evidence of toxicity in any of them, as it is a natural compound.

Tannin molecules were tested with the intent of finding an effective drug against HIV. Kilkuskie and colleagues observed gallotannins research showed inhibitory activity only at toxic concentrations, ellagitannins and condensed tannins inhibit viral replication and complex tannins have demonstrated potent activity against HIV replication. They concluded that anti-HIV activity by tannins exibida is due to inhibition of reverse transcriptase, thus hampering viral replication.

This justifies the high relevance of the research with a lower molecular weight tannins and lower toxicity.

DOCUMENTED SCIENTIFIC CASE STUDY FOR EXAMPLE

DBDS extract patient, 47, male, HIV status +/- 10 years ago, she began treatment with Pithecellobiun (Mutamba), on January 22, 2011, used for 30 days and conducted the following tests :

Complete blood count (03/02/11)

HT: 46.0%

Hm: 5.04

Hb: 16.10

Platelets: 126,000

Leukocytes: 3000

Objective: 62

Total Lymphocytes: 34

On lymphocytes: 1,020

B: 3

Complete blood count (25/08/11)

Ht: 39%

Hm: 4.3

Hb: 13

Platelets: 144,000

Leukocytes: 4200

Target: 46

Total Lymphocytes: 44

Related: 1848

PCR quantitative PCR (22/09/2011) - Alvaro Laboratory. Method RT - PCR (real abbot HIV Team I)

Result: not detected

Reference: not detected

Treatment with tannin extracted Pithecellobiun in inhibiting HIV reverse transcriptase PCR to zero. The complete blood count was made at the end of eight months and was normal.

RESULTS

Given the results, Dr. Gouveia, has been testing the molecules of tannin Mutamba, with the intention of finding an effective drug against HIV since according to their research, the virus of yellow fever and HIV are equal in terms of structure. In an interview, medical specialist, explains treatment directed at two people with HIV. Eight months after completion of treatment thereof, and the specific PCR tests such as blood tests that detect viral load were negative in relation to diagnosis of the disease outcome. This means that viruses replicate, they stopped in their multiplication in the body of patients, "They turned to zero viral load, and restored in 15 kg or 10 kg body weight, treatment efficacy is practically proven" says scientist and doctor, explaining that now scientists and technical reviews Biópcia is proven product efficacy and 100%. Dr. Gouveia also explains that because it is a natural remedy, has no contraindications and no ethical-moral impediment continuity and mass can be applied on the population infected. The treatment is only for people who have been identified with HIV virus.

EFFECTIVE TREATMENT UNDER PROTOCOL HIV

Time Management:

Treatment for patients with HIV only lasts thirty days.

Basic Ingredients of natural healing:

As the drug is still not chemically handled, the doctor gives the simple recipe on how to prepare the medicine on hand for consumption:

- Fifty leaves the tops of mature trees

- 2 liters of water

preparation:

The leaves should be mixed with 200 ml of pure water and ground in a blender.

After this procedure, add 1800 ml of water remaining. The patient should take the measure of a blender 200 ml, 2 times a day, every 12 hours. This must be administered every day for thirty consecutive days.

COMMENTS

The doctor stressed that effective treatment presented may depend on the region where the plant is Mutamba. In this case, its efficacy has been proven in plants that originated in climate and altitude of the states of Goiás and Tocantins. "You can not do any plants from other regions," he warns.

PROTOCOL FOR THE TREATMENT OF HIV AIDS

The full protocol for the treatment of HIV virus, is widely described in the following link in spanish and english:

http://cenic-mutamba-en.jimdo.com/projects/cure-against-hiv-1-virus/protocol-mgut/

PROPRIETARY RESEARCH

The discovery was patented and the October 19, 2010, Dr. Gouveia research, according to him, is already released by the National Patent Office, has called attention to the infectious diseases or infectious disease specialists from various parts of Brazil and the world, seeking to carry out the treatment of HIV positive patients. In collaboration with specialists in infectious diseases and carry out the treatment of one hundred patients Araguaína.

NEXT STEP

At the end of the interview, Dr. Gouveia reports that the request sent by the Centre for Research ITPAC through the course coordinator of Medicine, Dr. Elvio Machado, in order to continue studies in command of the Institute, "The application was well received by the coordinator.

TESTING

We test and retest in vitrio with 100% inhibition without cytotoxicity, and has followed the inoculated patients, all successfully.

People infected with HIV, who used the extract Guazulma ulmifolia (Mutamba) were treated to a great number, currently has more than a hundred people turned to zero viral load and CD4 standardized, fully documenting the successful process.

GOVERNMENT AND BUSINESS SUPPORT NEEDED

And currently effective and proven project does not yet have the support of the federal government or medical institution. Currently the research project has been paid for by funds and resources.

Support So that is desired is necessary to inoculate as many sick and help people globally. Government support of governments in the world, in each country to eliminate the virus completely will need.

Therefore the support of all governments and social organizations, living institutions is needed to help stop the HIV virus and AIDS Project bring Mutamba meet the initial objectives of curing to the large number of people infected and suffering from this evil.

INITIAL INVESTIGATION

Faina in 1946 in Goias, scientific Dr.Francisco Cabral de Melo discovered that could eradicate the Mutamba plant, yellow fever virus, being a pharmacist with experience in medicine, used the substrate Mutamba in patients with yellow fever, with a cure rate of 100% of treated patients, after three days of using the extract out of the coma patients recovered completely.

DISCOVERY PERFORMED

Then a study on the virus of yellow fever developed, the yellow fever virus is a retro virus RNA with HIV-like virus structures. The research project began ten years ago, under the direction of scientific and Dr. Antonio Rodrigues Paulo Gouveia, studying Guazulma ulmifolia (Mutamba) plant by observing its peculiarities, being a medium-sized plant, typical of areas locked and transition zones to the Amazon rainforest, it was discovered that the trees in the states of Goiás and Tocantins have this special feature, shown in secondary metabolites, a tannin that is effective in detecting virus inhibitor.

By studying articles related to the tree Guazulma ulmifolia (Mutamba) similar trees in eastern Mexico south to Paraguay, only the tree has latters effectiveness of a viral inhibitor reported, yet this study, research was begun and literature review, with more emphasis on tree latters.

The October 23, 2010, the project was presented at the Seminar on AIDS research in Porto Alegre RS, began soon after that, a lot of expectation in relation to the project, it was reported in several magazines, newspapers and local television stations topic, many people took for themselves the Mutamba extract, according to the preparation and the application protocol, without toxic effects spread.

One of the laboratories that offer support in the reports and that worked was the Kyolab Laboratory, which showed great clinical improvement and weight gain of recovered patients. In 2011 again the laboratory Kyolab ltda of Campinas sp, performed in vitro tests, in June 2011, the in vitro tests were ready, resulting in an inhibition of HIV by 30 percent in initial phase, shortly after he was done another test by Dr. Amilcar Tanure at Federal University of Rio de Janeiro (RJ), with a new value that gave 100% inhibition of the HIV virus without cellular cytotoxicity, the extract was purified after these results.

SCIENTIFIC CENTERS AND INSTITUTIONS INVOLVED IN THE PROJECT

Scientific institutions involved in the project were: Research Institute President Antonio Carlos Tocantinense (ITPAC) Araguaína-Tocantins, Laboratory of Campinas SP Kyolab Ltda (Kyolab.com.br), the Research Project and Seminar on HIV AIDS Porto Alegre RS and the Laboratory of Molecular Virology, Department of Genetics, Federal University of Rio de Janeiro (RJ), with whom also worked permanently.

PUBLIC COMPLAINT TO THE WORLD

Currently 2014, should be reported that there is great international pressure from the global drug empire on the Mutamba project as successful and proven not wish to be known and applied massively in the population and try to close the forcibly financing. Pilot tests developed have benefited yet tens and hundreds of people, meeting and being tested in humans, which even were in a situation of critical phase, infected with HIV virus, AIDS status. The results obtained and the research team showed that the Guazulma ulmifolia, has a surprising power in the total viral inhibition of HIV virus. The project is open for contact with health organizations and institutions and governments.

CONTACT WITH PROJECT MANAGER OF MUTAMBA PROJECT AGAINST HIV

CRM-2107-TO Medical and Scientific - Project Manager

Dr. Paulo Antônio Rodrigues Gouveia

Brasil, resident na rua, number 236, couto Sector, Araguaina

CONTACT AND POSTAL AREA FOR GOVERNMENTS AND SCIENTIFIC INSTITUTIONS:

emails:

Primary: paulogouveia.gouveia@bol.com.br (CHIEF GLOBAL PROJECT)

Secondary: paulogouveia.gouveia@gmail.com

Call Center : supplyarea.mutambaproject@gmx.com

phone:

Research Center: +55633414 0719

Head of Global Mobile Phone Project: +5563 9263 2664